Russell J. Cox

2017 - Jazz Pharmaceuticals

In 2017, Russell J. Cox earned a total compensation of $3.2M as Former Executive Vice President and COO at Jazz Pharmaceuticals, a 10% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$162,000
Option Awards$1,060,658
Salary$587,692
Stock Awards$1,361,800
Other$10,722
Total$3,182,872

Cox received $1.4M in stock awards, accounting for 43% of the total pay in 2017.

Cox also received $162K in non-equity incentive plan, $1.1M in option awards, $587.7K in salary and $10.7K in other compensation.

Rankings

In 2017, Russell J. Cox's compensation ranked 3,378th out of 14,666 executives tracked by ExecPay. In other words, Cox earned more than 77.0% of executives.

ClassificationRankingPercentile
All
3,378
out of 14,666
77th
Division
Manufacturing
1,159
out of 5,772
80th
Major group
Chemicals And Allied Products
319
out of 2,075
85th
Industry group
Drugs
245
out of 1,731
86th
Industry
Pharmaceutical Preparations
194
out of 1,333
85th
Source: SEC filing on June 15, 2018.

Cox's colleagues

We found five more compensation records of executives who worked with Russell J. Cox at Jazz Pharmaceuticals in 2017.

2017

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2017

Suzanne Hooper

Jazz Pharmaceuticals

Executive Vice President and GC

2017

Matthew Young

Jazz Pharmaceuticals

Chief Financial Officer

2017

Karen Smith

Jazz Pharmaceuticals

Chief Marketing Officer

2017

Michael Miller

Jazz Pharmaceuticals

Executive Vice President U.S Commercial

News

You may also like